12 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27816515	143	Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors.	Merck
27727125	24	Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators.	Pfizer
27490827	24	Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy.	Pfizer
24900695	19	Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators.	Chinese Academy of Sciences
31757666	314	Discovery and optimization of heteroaryl piperazines as potent and selective PI3K? inhibitors.	Merck
31744674	23	Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPK?2?1?1 activators.	Nanjing University of Chinese Medicine
30036059	40	Acyl Glucuronide Metabolites of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1 H-indole-3-carboxylic Acid (PF-06409577) and Related Indole-3-carboxylic Acid Derivatives are Direct Activators of Adenosine Monophosphate-Activated Protein Kinase (AMPK).	Pfizer
29620890	25	Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations.	Glaxosmithkline
28345906	9	Malonylginsenosides with Potential Antidiabetic Activities from the Flower Buds of Panax ginseng.	Chinese Academy of Sciences
29035567	38	Hit-to-Lead Optimization and Discovery of 5-((5-([1,1'-Biphenyl]-4-yl)-6-chloro-1H-benzo[d]imidazol-2-yl)oxy)-2-methylbenzoic Acid (MK-3903): A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein Kinase.	Metabasis Therapeutics